Detalles de la búsqueda
1.
Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma.
Immunol Invest
; 51(5): 1498-1514, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34486463
2.
PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma.
Mod Pathol
; 34(11): 1966-1978, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34218257
3.
Genetic landscape of external auditory canal squamous cell carcinoma.
Cancer Sci
; 111(8): 3010-3019, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32500594
4.
Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.
Cancer
; 126(18): 4177-4187, 2020 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32648953
5.
A case of peritoneal metastasis during treatment for hypopharyngeal squamous cell carcinoma.
World J Surg Oncol
; 14(1): 265, 2016 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-27756320
6.
[Spindle Cell Carcinoma of the Head and Neck: A Report of 6 Cases].
Nihon Jibiinkoka Gakkai Kaiho
; 118(2): 123-8, 2015 Feb.
Artículo
en Japonés
| MEDLINE | ID: mdl-26336792
7.
Prevalence of human papillomavirus in oropharyngeal cancer: a multicenter study in Japan.
Oncology
; 87(3): 173-82, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25033838
8.
[A case of squamous cell carcinoma of the hard palate in a patient with basal cell nevus syndrome].
Nihon Jibiinkoka Gakkai Kaiho
; 117(6): 815-20, 2014 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-25102740
9.
Acquired tracheobronchomalacia developed following voice prosthesis implantation.
Auris Nasus Larynx
; 51(3): 433-436, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520973
10.
Correction: Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter clinical study.
PLoS One
; 19(5): e0303720, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722895
11.
Extent of thyroidectomy and paratracheal lymph node dissection in total pharyngolaryngectomy for pyriform sinus cancer, and recurrence, survival, and postoperative hypoparathyroidism: A multicenter retrospective study.
Head Neck
; 46(2): 269-281, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37955187
12.
Efficacy of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine for the prevention of mucositis induced by platinum-based chemoradiation in head and neck cancer: A phase II study.
Clin Nutr ESPEN
; 57: 730-734, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37739730
13.
Pembrolizumab Monotherapy Versus Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma.
In Vivo
; 37(5): 2188-2196, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37652513
14.
A novel approach to predict acute radiation dermatitis in patients with head and neck cancer using a model based on Bayesian probability.
Phys Med
; 116: 103181, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38000101
15.
Immune Checkpoint Inhibitors for Nasopharyngeal Carcinoma in a Real-world Setting in Japan.
In Vivo
; 37(2): 747-755, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36881083
16.
Five-year Follow-up of Patients With Head and Neck Cancer Treated With Nivolumab and Long-term Responders for Over Two Years.
In Vivo
; 36(4): 1881-1886, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35738615
17.
Inflammation-based Prognostic Score as a Prognostic Biomarker in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab Therapy.
In Vivo
; 36(2): 907-917, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35241549
18.
Real-world Experience With Pembrolizumab for Advanced-stage Head and Neck Cancer Patients: A Retrospective, Multicenter Study.
Anticancer Res
; 42(7): 3653-3664, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35790253
19.
Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study.
PLoS One
; 17(7): e0271907, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35901098
20.
Retrospective Study of Cisplatin/Carboplatin, 5-Fluorouracil Plus Cetuximab (EXTREME) for Advanced-stage Salivary Gland Cancer.
In Vivo
; 36(2): 979-984, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35241559